Skip to main content
Clinical Trials/NL-OMON46328
NL-OMON46328
Completed
Not Applicable

QUANtification of Cardiovascular Autonomic Neuropathy (CAN) and the effects of anaesthesia on hemodynamics and cerebral perfusion - QUANCAN Study

Academisch Medisch Centrum0 sites45 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Autonomic neuropathy as a result of diabetes
Sponsor
Academisch Medisch Centrum
Enrollment
45
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Observational non invasive

Investigators

Eligibility Criteria

Inclusion Criteria

  • Willing and able to give written informed consent, scheduled for elective, non\-cardiothoracic surgery under general anesthesia and age 18 years and above

Exclusion Criteria

  • Day case surgery, laparoscopic procedure, DM type 1, Parkinson\*s disease, uncontrolled cardiac arrhythmia, Pure autonomic failure (formerly called idiopathic orthostatic hypotension), Multiple system atrophy with autonomic failure (formerly called Shy\-Drager syndrome), Addison\*s disease and hypopituitarism, pheochromocytoma, peripheral autonomic neuropathy (e.g., amyloid neuropathy, idiopathic autonomic neuropathy), known cardiomyopathy, extreme left ventricle hypertrophy or ejection fraction \< 30%, proven or suspected allergy for any of the medication used during induction of anaesthesia, malignant hyperthermia, unability to record transcranial doppler ultrasound due to anatomical variance.

Outcomes

Primary Outcomes

Not specified

Similar Trials